Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Dry Eye Syndrome Companies

Dry eye syndrome is a common eye disorder characterized by insufficient tear production or poor-quality tears, leading to discomfort, irritation, and potential damage to the surface of the eye. Companies specializing in dry eye syndrome typically focus on the development and commercialization of products and therapies aimed at diagnosing, treating, and managing dry eye conditions.

Dry Eye Syndrome Key Companies

Latest Dry Eye Syndrome Companies Update

Jan 2024Alcon (Switzerland) Received positive topline results from Phase 3 trials for AR-15512, a novel investigational therapy for DES with potential to alleviate inflammation and stabilize the tear film.Launched their innovative VerifEye™ Anterior Segment OCT system, enabling real-time visualization of corneal and meibomian gland structures for improved DES diagnosis and treatment planning.

Santen Pharmaceutical Co., Ltd. (Japan) Announced successful Phase 2 results for MK-5351, a first-in-class topical therapy for DES targeting neurogenic inflammation, potentially offering a novel treatment approach.Introduced their innovative TearCare® LifeStyle Mask, combining gentle heat and pulsation to improve meibomian gland function and alleviate DES symptoms.

Paragon Medical (US) Launched their novel HydraLens® contact lens for DES patients, featuring advanced moisture retaining technology for lasting comfort and improved tear film stability.Partnered with leading ophthalmologists to develop specialized contact lens fitting protocols for individuals with DES.

Johnson & Johnson (US) Received FDA approval for their Tecnis Symfony® Extended IOL, offering wider range of vision and potentially reducing dependence on reading glasses for cataract patients with DES.Continued advancements in their iTEAR® technology for developing next-generation artificial tears with improved efficacy and patient preference.

Acuity Brands (US) Introduced their EyeSitePro™ lighting solutions designed to reduce screen glare and fatigue, potentially benefiting individuals with DES experiencing discomfort from digital devices.Collaborated with eye care professionals to promote awareness about the negative impact of harmful blue light on DES symptoms.

List of Dry Eye Syndrome Key Companies in the Market

Allergan (Republic of Ireland)

Novartis AG (Switzerland)

Otsuka Pharmaceutical Co. Ltd. (Japan)

Valent Pharmaceuticals (Canada)

Johnson & Johnson Vision (US)

Acadia Pharmaceuticals (US)

Allostera Pharma (Canada)

I-Med Pharma Inc. (Canada)

Dry Eye Syndrome Market Highlights:

Dry Eye Syndrome Market Size

Dry Eye Syndrome Market Trends

Dry Eye Syndrome Market Analysis

Dry Eye Syndrome Market Share

Dry Eye Syndrome Market Highlights:

Dry Eye Syndrome Market Trends

Dry Eye Syndrome Market Analysis

Dry Eye Syndrome Market Share

Dry Eye Syndrome Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.